Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones.

Source:http://linkedlifedata.com/resource/pubmed/id/12540232

J. Med. Chem. 2003 Jan 30 46 3 349-52

Download in:

View as

Triples

General Info

PMID
12540232